Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant oral magnesium supplementation for alcohol withdrawal syndrome
2016-002072-26Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol withdrawal syndrome (AWS) comparing Magnesium supplementation arm with Placebo arm (2 arms). Started Jan 2021; status: completed.
02
Drugs
magnesium
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on 2016-002072-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002072-26.